REUTERS
Ukraine s Health Ministry on February 22 certified the Oxford/AstraZeneca (Covishield) vaccine against COVID-19 for emergency use in the country. The Oxford/AstraZeneca vaccine, which is produced at the facilities of the Serum Institute (India), has a local (trade) name Covishield. Accordingly, the Covishield vaccine, which is arriving in Ukraine today, is officially registered. Oxford/AstraZeneca (Covishield) filed for registration with the Health Ministry s State Expert Center on February 15. A law is in effect in Ukraine that simplifies the registration procedure for vaccines against COVID-19 and reduces it to five working days, the ministry s press service reported on Facebook.
Read alsoUkraine to get 15 mln doses of NovaVax vaccine – health ministerIt is noted the vaccine was developed by Oxford University and the British-Swedish AstraZeneca. The Oxford/AstraZeneca vaccine has already been approved by the World Health Organization, as well as by the UK, the Euro